Twist Bioscience (TWST) Competitors $28.59 +2.12 (+8.01%) Closing price 04:00 PM EasternExtended Trading$28.38 -0.21 (-0.74%) As of 06:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TWST vs. ADPT, BEAM, CRSP, NTLA, TXG, VCYT, LEGN, RVMD, RYTM, and RNAShould you be buying Twist Bioscience stock or one of its competitors? The main competitors of Twist Bioscience include Adaptive Biotechnologies (ADPT), Beam Therapeutics (BEAM), CRISPR Therapeutics (CRSP), Intellia Therapeutics (NTLA), 10x Genomics (TXG), Veracyte (VCYT), Legend Biotech (LEGN), Revolution Medicines (RVMD), Rhythm Pharmaceuticals (RYTM), and Avidity Biosciences (RNA). These companies are all part of the "medical" sector. Twist Bioscience vs. Its Competitors Adaptive Biotechnologies Beam Therapeutics CRISPR Therapeutics Intellia Therapeutics 10x Genomics Veracyte Legend Biotech Revolution Medicines Rhythm Pharmaceuticals Avidity Biosciences Adaptive Biotechnologies (NASDAQ:ADPT) and Twist Bioscience (NASDAQ:TWST) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, media sentiment, risk and valuation. Does the media prefer ADPT or TWST? In the previous week, Adaptive Biotechnologies had 3 more articles in the media than Twist Bioscience. MarketBeat recorded 12 mentions for Adaptive Biotechnologies and 9 mentions for Twist Bioscience. Twist Bioscience's average media sentiment score of 1.11 beat Adaptive Biotechnologies' score of 0.48 indicating that Twist Bioscience is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adaptive Biotechnologies 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Twist Bioscience 6 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate ADPT or TWST? Adaptive Biotechnologies presently has a consensus target price of $12.38, indicating a potential downside of 4.81%. Twist Bioscience has a consensus target price of $49.40, indicating a potential upside of 72.79%. Given Twist Bioscience's higher probable upside, analysts plainly believe Twist Bioscience is more favorable than Adaptive Biotechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adaptive Biotechnologies 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88Twist Bioscience 1 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.73 Which has more volatility & risk, ADPT or TWST? Adaptive Biotechnologies has a beta of 1.92, indicating that its stock price is 92% more volatile than the S&P 500. Comparatively, Twist Bioscience has a beta of 2.36, indicating that its stock price is 136% more volatile than the S&P 500. Which has preferable valuation and earnings, ADPT or TWST? Adaptive Biotechnologies has higher earnings, but lower revenue than Twist Bioscience. Twist Bioscience is trading at a lower price-to-earnings ratio than Adaptive Biotechnologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdaptive Biotechnologies$205.22M9.65-$159.49M-$0.82-15.85Twist Bioscience$312.97M5.51-$208.73M-$1.45-19.72 Do insiders & institutionals believe in ADPT or TWST? 99.2% of Adaptive Biotechnologies shares are held by institutional investors. 6.4% of Adaptive Biotechnologies shares are held by company insiders. Comparatively, 3.0% of Twist Bioscience shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is ADPT or TWST more profitable? Twist Bioscience has a net margin of -23.51% compared to Adaptive Biotechnologies' net margin of -59.07%. Twist Bioscience's return on equity of -29.03% beat Adaptive Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets Adaptive Biotechnologies-59.07% -60.93% -23.03% Twist Bioscience -23.51%-29.03%-21.77% SummaryAdaptive Biotechnologies and Twist Bioscience tied by winning 8 of the 16 factors compared between the two stocks. Get Twist Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TWST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TWST vs. The Competition Export to ExcelMetricTwist BioscienceMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.73B$3.09B$5.82B$9.73BDividend YieldN/A2.23%3.84%4.09%P/E Ratio-19.7221.1431.1525.96Price / Sales5.51398.37475.15122.97Price / CashN/A43.0937.1558.38Price / Book3.618.079.116.39Net Income-$208.73M-$54.72M$3.26B$265.56M7 Day Performance1.67%2.62%2.11%1.98%1 Month Performance-20.21%7.63%5.12%1.33%1 Year Performance-32.67%13.11%31.25%21.15% Twist Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TWSTTwist Bioscience4.1868 of 5 stars$28.59+8.0%$49.40+72.8%-40.0%$1.73B$312.97M-19.72990Positive NewsADPTAdaptive Biotechnologies2.4692 of 5 stars$12.15-0.4%$12.38+1.9%+174.0%$1.85B$178.96M-14.82790Analyst RevisionBEAMBeam Therapeutics2.1067 of 5 stars$17.17-2.6%$48.45+182.2%-37.2%$1.74B$63.52M-3.82510CRSPCRISPR Therapeutics3.8292 of 5 stars$55.41+0.7%$71.60+29.2%+5.7%$5.04B$37.31M-10.20460NTLAIntellia Therapeutics4.5758 of 5 stars$10.74-0.5%$30.68+185.7%-57.1%$1.11B$57.88M-2.29600TXG10x Genomics3.9007 of 5 stars$12.31+0.2%$13.63+10.7%-43.1%$1.52B$644.47M-17.591,240VCYTVeracyte2.8594 of 5 stars$27.99+2.3%$40.90+46.1%-7.0%$2.20B$445.76M84.82790News CoveragePositive NewsLEGNLegend Biotech3.7026 of 5 stars$36.24-2.1%$73.33+102.4%-37.1%$6.66B$728.30M-61.422,609RVMDRevolution Medicines4.4199 of 5 stars$34.70-0.9%$68.82+98.3%-19.4%$6.49B$11.58M-7.71250Positive NewsAnalyst RevisionRYTMRhythm Pharmaceuticals3.8106 of 5 stars$94.31+2.5%$101.57+7.7%+124.1%$6.26B$130.13M-31.33140News CoveragePositive NewsRNAAvidity Biosciences3.2165 of 5 stars$45.75-1.2%$67.00+46.4%-0.8%$5.51B$8.93M-15.25190Options Volume Related Companies and Tools Related Companies Adaptive Biotechnologies Alternatives Beam Therapeutics Alternatives CRISPR Therapeutics Alternatives Intellia Therapeutics Alternatives 10x Genomics Alternatives Veracyte Alternatives Legend Biotech Alternatives Revolution Medicines Alternatives Rhythm Pharmaceuticals Alternatives Avidity Biosciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TWST) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Twist Bioscience Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Twist Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access